Advances in Structure-Based Drug Design Targeting Membrane Protein Markers in Prostate Cancer

August 2024 in “ Drug Discovery Today ”

J.P. Batista-Silva, Diana Gomes, Sérgio F. Sousa, Ângela Sousa, Luís A. Passarinha

membrane proteins prostate cancer biomarkers inhibitors computer-aided drug design CADD structure-based drug design

Studysummary This review examines advances in computer-aided drug design for targeting membrane proteins in prostate cancer but reports no new clinical results; it emphasizes the potential of structural insights and compound screening for therapeutic development.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This review discusses the challenges and advancements in targeting membrane proteins (MPs) for prostate cancer (PCa) treatment. MPs are significant in PCa progression and present promising therapeutic targets, but experimental limitations have hindered effective biomarker and inhibitor discovery. The review highlights the role of computational methods, particularly computer-aided drug design (CADD), in overcoming these barriers by providing structural insights and enabling the screening of large compound libraries. These approaches facilitate the identification and optimization of leads, focusing on structure-based strategies targeting key membrane-bound PCa biomarkers.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

Bioactive Metabolites of Edible Mushrooms Efficacious Against Androgenic Alopecia: Targeting SRD5A2 Using Computational Approach

research Bioactive Metabolites of Edible Mushrooms Efficacious Against Androgenic Alopecia: Targeting SRD5A2 Using Computational Approach

November 2022 in “Journal of Herbal Medicine”

This study suggests that three mushroom-derived bioactive compounds, Zhankuic acid A, Sterenin M, and Melleolide K, may effectively inhibit SRD5A2 and stabilize its interaction, indicating potential for treating androgenic alopecia.

research Phytochemical, Chemotaxonomic and Bioinformatics Study on Laportea Bulbifera (Urticaceae)

6 citations , May 2022 in “Chemistry & biodiversity”

This study identified compounds from Laportea bulbifera with potential inhibitory effects on human steroid 5α-reductase 2, suggesting their application in treating benign prostatic hyperplasia.

research Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2

14 citations , April 2021 in “Biology”

This study found that ethanol extract of Tubtim Chumphae rice bran downregulates SRD5A gene expression, similarly to finasteride, suggesting potential use as an anti-hair loss product.

research Structure of Human Steroid 5α-Reductase 2 with the Anti-Androgen Drug Finasteride

30 citations , October 2020 in “Nature Communications”

This study provides the first crystal structure of the human SRD5A2 enzyme, revealing key insights into its function and inhibition which may aid future drug development.

research Homology Modeling of 5-Alpha-Reductase 2 Using Available Experimental Data

5 citations , January 2018 in “Interdisciplinary sciences: computational life sciences”

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

research Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents

148 citations , April 2009 in “Molecular Pharmaceutics”

This study reports that three synthesized PSMA-targeted radioimaging agents demonstrated high affinity and specific localization to prostate cancer tumors in a mouse model, highlighting their potential for cancer detection and monitoring.